Related Experiment Video
Updated: Aug 23, 2025

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Pediatric Tuberculosis Diagnostics: Present and Future
Francesca Wanda Basile1, Pamela Nabeta2, Morten Ruhwald2
1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Insights
Diagnosing pediatric tuberculosis remains challenging due to various factors. However, recent advancements in rapid molecular assays and child-friendly testing methods offer improved detection for children with tuberculosis.
Area of Science:
- Pediatric Infectious Diseases
- Diagnostic Microbiology
- Global Health
Background:
- Current diagnostic methods for pediatric tuberculosis are insufficient, leading to under-diagnosis.
- Challenges include lack of specific symptoms, low bacterial counts, difficult sample collection, and limited access to tools in high-burden areas.
Purpose of the Study:
- To highlight recent advancements in pediatric tuberculosis diagnostics.
- To emphasize the need for child-specific considerations in developing new diagnostic tests.
Main Methods:
- Review of recent progress in novel diagnostic assays for pediatric tuberculosis.
- Inclusion of WHO-endorsed rapid molecular assays and alternative specimen types like stool.
- Identification of candidate biomarkers based on host immune response.
Main Results:
- WHO-endorsed rapid molecular assays show promise for decentralized testing.
- Stool samples are now recommended as a child-friendly alternative for GeneXpert testing.
- A growing pipeline of assays in development and new biomarkers are emerging.
Conclusions:
- Encouraging progress is being made in pediatric tuberculosis diagnostics.
- New assays and biomarkers are expanding testing capabilities.
- Considering the unique needs of children is crucial for developing effective diagnostic tools that meet WHO priorities.
Abstract:
The current diagnostic abilities for the detection of pediatric tuberculosis are suboptimal. Multiple factors contribute to the under-diagnosis of intrathoracic tuberculosis in children, namely the absence of pathognomonic features of the disease, low bacillary loads in respiratory specimens, challenges in sample collection, and inadequate access to diagnostic tools in high-burden settings. Nonetheless, the 2020s have witnessed encouraging progress in the area of novel diagnostics. Recent WHO-endorsed rapid molecular assays hold promise for use in service decentralization strategies, and new policy recommendations include stools as an alternative, child-friendly specimen for testing with the GeneXpert assay. The pipeline of promising assays in mid/late-stage development is expanding, and novel pediatric candidate biomarkers based on the host immune response are being identified for use in diagnostic and triage tests. For a new test to meet the pediatric target product profiles prioritized by the WHO, it is key that the peculiarities and needs of the hard-to-reach pediatric population are considered in the early planning phases of discovery, validation, and implementation studies.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...